Genovare Peptides | KLOW 150 mg Pen

What It Is KLOW is a proprietary quad-peptide research blend combining four complementary bioactive peptides in a single lyophilised formulation: GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex), BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 fragment), and KPV (Lys-Pro-Val). Each component targets a distinct cellular signalling pathway. GHK-Cu modulates ECM remodelling and gene expression; BPC-157 activates VEGFR2-Akt and FAK-paxillin pathways to promote angiogenesis and fibroblast migration; TB-500 regulates actin polymerisation, cell migration, and endothelial regeneration; and KPV suppresses pro-inflammatory cytokine signalling via the NF-κB pathway. The combination is designed to investigate the synergistic potential of simultaneous multi-pathway targeting in regenerative biology.

How It Is Used KLOW is reconstituted with bacteriostatic water and administered via subcutaneous injection. Research applications include multi-pathway wound healing models, connective tissue repair studies, immune modulation research, angiogenesis investigations, and skin regeneration biology.